See more : Grafton Group plc (GFTU.L) Income Statement Analysis – Financial Results
Complete financial analysis of Movano Inc. (MOVE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Movano Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- Servotronics, Inc. (SVT) Income Statement Analysis – Financial Results
- Metals Australia Ltd (MLS.AX) Income Statement Analysis – Financial Results
- Azrieli Group Ltd (AZRG.TA) Income Statement Analysis – Financial Results
- Australian Agricultural Projects Ltd (AAP.AX) Income Statement Analysis – Financial Results
- Social Capital Suvretta Holdings Corp. IV (DNAD) Income Statement Analysis – Financial Results
Movano Inc. (MOVE)
About Movano Inc.
Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medtech and consumer devices. Its platform uses radiofrequency technology, which enables the creation of sensors that are small enough to fit into wearable devices and other small form factors. The company develops Movano Ring that measures heart rate, heart rate variability, sleep, respiration, temperature, blood oxygen saturation, steps, and calories, as well as incorporates women-centric features and design. It is also developing non-invasive continuous glucose monitoring and cuffless blood pressure monitoring features to its technology platform. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 158.00K | 134.00K | 74.00K | 13.00K | 11.00K | 3.00K |
Gross Profit | -158.00K | -134.00K | -74.00K | -13.00K | -11.00K | -3.00K |
Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 16.89M | 18.99M | 13.43M | 8.37M | 6.52M | 2.89M |
General & Administrative | 0.00 | 1.93K | 6.38M | 2.73M | 2.00M | 662.18K |
Selling & Marketing | 0.00 | 11.47M | 0.00 | 0.00 | 0.00 | -58.18K |
SG&A | 12.80M | 11.47M | 6.38M | 2.73M | 2.00M | 604.00K |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 72.00K | 0.00 |
Operating Expenses | 29.69M | 30.46M | 19.80M | 11.11M | 8.51M | 3.49M |
Cost & Expenses | 29.69M | 30.46M | 19.80M | 11.11M | 8.51M | 3.50M |
Interest Income | 0.00 | 133.00K | 22.00K | 27.00K | 59.00 | 0.00 |
Interest Expense | 0.00 | 133.00K | 883.00K | 1.00M | 0.00 | 0.00 |
Depreciation & Amortization | 158.00K | 134.00K | 74.00K | 13.00K | 11.00K | 3.00K |
EBITDA | -29.13M | -30.20M | -20.82M | -11.07M | -8.50M | -3.49M |
EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -29.69M | -30.46M | -19.80M | -11.11M | -8.51M | -3.50M |
Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | 407.00K | 133.00K | -1.97M | -1.92M | 72.00K | 8.00K |
Income Before Tax | -29.28M | -30.33M | -21.77M | -13.03M | -8.44M | -3.49M |
Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | -133.00K | 809.00K | 1.00M | -160.86K | 0.00 |
Net Income | -29.28M | -30.20M | -22.58M | -14.04M | -8.44M | -3.49M |
Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | -9.51 | -13.71 | -10.34 | -6.55 | -3.94 | -1.63 |
EPS Diluted | -9.51 | -13.71 | -10.34 | -6.55 | -3.94 | -1.63 |
Weighted Avg Shares Out | 3.08M | 2.20M | 2.18M | 2.14M | 2.14M | 2.14M |
Weighted Avg Shares Out (Dil) | 3.08M | 2.20M | 2.18M | 2.14M | 2.14M | 2.14M |
Movano Health Provides Business Update and Reports Third Quarter 2023 Financial Results
Movano Health Prices $3.6 Million Public Offering
Movano Inc. to Report Third Quarter 2023 Financial Results on Wednesday, November 15, 2023
Movano Health Announces Proposed Public Offering
Movano Inc. to Report Third Quarter 2023 Financial Results Tuesday, November 14, 2023
Movano Health's Proprietary Chip and Prototype Achieves Accuracy Commensurate with the FDA's Requirements for Blood Pressure Monitoring
Movano Health to Launch the Evie Ring on November 20
PowerTap Hydrogen Fueling Corp. and Coleman Industrial Gases, LLC Sign a Strategic Partnership-based "Letter of Intent" to Negotiate and Execute a CO2 and Hydrogen Purchase Agreement
Evie Ring Welcomes Cardiologist and Stanford University Associate Professor Dr. Fátima Rodriguez to its Medical Advisory Board
Movano Health, Maker of the Evie Ring, Selects Jay Group as its Fulfillment Provider in Preparation for its Commercial Launch
Source: https://incomestatements.info
Category: Stock Reports